ArticleFrontiers in oncology2024

A historical controlled study of domestic trastuzumab and pertuzumab in combination with docetaxel for the neoadjuvant treatment of early HER2-positive breast cancer.

Dongdong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.